Uncategorized Archives - Page 11 of 134

MondayJun 10, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Is ‘One to Watch’

Recent Achievements Annovis Bio recently announced statistically significant data from its Phase II/III Alzheimer’s study, showcasing Buntanetap’s potential to improve cognition in patients with mild AD Annovis Bio recently announced last patient last visit in the Phase III study of Buntanetap in patients with early Parkinson’s disease and expects data announcement in June 2024, marking significant progress in expanding its therapeutic reach The company has solidified strategic partnerships to enhance its research capabilities and broaden its market reach Investment Considerations Unique Market Position: Annovis Bio is the only company developing a drug for both AD and PD that inhibits multiple neurotoxic…

WednesdayJun 05, 2024 10:30 am

Astrotech Corp. (NASDAQ: ASTC) Subsidiary, “1st Detect”, Focuses on Superior Narcotics Trace Detection For Airport and Other Security Sites

Astrotech Corporation Subsidiary 1st Detect Approved as GSA Vendor; Introduces Advanced Narcotics Trace Detection Technology 1st Detect has now received approval from the U.S. General Services Administration (“GSA”) as an authorized vendor for government-related applications 1st Detect recently introduced a state-of-the-art Narcotics Trace Detection (“NTD”) narcotics library, which is particularly useful for detection at points of entry and government agencies involved in combating the illicit drug trade 1st Detect's portfolio now includes the TRACER 1000, Explosives Trace Detection (“ETD”) and Narcotics Trace detection Astrotech (NASDAQ: ASTC), through its subsidiary 1st Detect, is revolutionizing narcotics and explosives trace detection. With recent…

TuesdayJun 04, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Updates on ACT-EAP for CNM-Au8(R) Compassionate Use

Clene announced significant updates to their NIH-funded Accelerating Access to Critical Therapies Expanded Access Program (ACT-EAP) for CNM-Au8(R) compassionate use in amyotrophic lateral sclerosis (“ALS”) Clene has optimized its manufacturing, operational, and personnel processes to expand the program’s capacity to accommodate up to 180 participants The ACT-EAP, a collaboration among Clene, Columbia University, and Synapticure, was funded by the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS), signed into law by Congress and President Biden in December 2021 Clene (NASDAQ: CLNN) and its subsidiary, Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to improving mitochondrial health and protecting…

MondayJun 03, 2024 8:45 am

HealthLynked Corp. (HLYK) Continues to Expand AI Capabilities

HealthLynked is at the forefront of revolutionizing global healthcare related solutions for patients, doctors, and related healthcare organizations Some of the company’s solutions, including the HealthLynked Network, Augmented Real-Time Interface, and the new AI chat feature, incorporate artificial intelligence capabilities to foster better patient outcomes for all The new AI chat feature is designed to assist patients in locating healthcare providers across the country using markers such as name, specialty, or location and significantly enhance the effectiveness of the HealthLynked Concierge Team in reducing wait times and offering 24/7 service to users HealthLynked continues to lead in the development of…

WednesdayMay 29, 2024 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Shares Corporate Update and Commitment to Advancing Therapies for Neurological Disorders, Prepares for Key Engagements with the FDA

PaxMedica is preparing to submit a New Drug Application to the U.S. Food and Drug Administration later this year for using suramin to treat Human African Trypanosomiasis PaxMedica is currently preparing for an associated and very important Type C meeting with the FDA scheduled for June 27th Type C meetings are designated by the FDA to address specific issues in drug development, such as clinical trial design, data requirements, or other scientific matters not covered by Type A or Type B meetings PaxMedica (NASDAQ: PXMD), a biopharmaceutical company specializing in neurological disorder treatments, recently shared corporate updates regarding its continued…

FridayMay 24, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Participates in Three Investor Conferences During May 2024, Promoting CNM-Au8(R) Neuronal Health Therapy

Clene recently participated in the Mizuho Neuroscience Summit 2024, the Benchmark 2024 Healthcare House Call Virtual Conference, and the Virtual A.G.P. Healthcare Conference CNM-Au8(R) is oral suspension developed to restore neuronal health and function by increasing energy production and utilization The therapy has been involved in clinical trials and compassionate use programs, accumulating over 600 years of exposure across various neurodegenerative conditions, with no safety concerns reported Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”), and Parkinson’s disease, recently…

FridayMay 24, 2024 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis

PaxMedica has received an urgent plea from the Ministry of Health of Malawi for emergency access to IV suramin to prevent a potential humanitarian crisis due to dwindling supplies of essential drugs used to save lives in the region PaxMedica has previously concluded a Type B meeting with the FDA in preparation for the NDA submission, focusing on the use of PAX-101 in treating the rare and fatal trypanosomal infection, Trypanosoma brucei rhodesiense, transmitted by tsetse flies PaxMedica also aims to potentially qualify for a Priority Review Voucher under the Neglected Tropical Disease Priority Review Voucher Program, which could provide…

ThursdayMay 23, 2024 9:00 am

HealthLynked Corp. (HLYK) Can Add Tens-of-thousands of Members by Improving Care for Students vis-à-vis its Affinity Marketing Efforts to U.S. Universities

The HealthLynked platform provides secure and quick access for patient/doctor records communication, supporting all types of health related utilization, including telemedicine and remote student applications University health clinics often face challenges when transferring medical records – and this limits coordinated care for students The HealthLynked platform provides a streamlined approach to medical records access, allowing students to securely share their health information with relevant parties HealthLynked (OTCQB: HLYK) is a company on a mission to build a superior healthcare system through the efficient integration of patient histories, genetic data, and demographic insights, into a sophisticated AI-driven platform that streamlines patient care…

TuesdayMay 21, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Key Operational Highlights as part of First Quarter 2024 Financial Results

Clene presented clinical data at the 2024 American Academy of Neurology (“AAN”) Annual Meeting, demonstrating that long-term CNM-Au8® treatment resulted in significant evidence of repair and remyelination across multiple paraclinical endpoints Clene entered into a sub-award grant agreement with Columbia University under the previously announced National Institute of Health (“NIH”) Grant Clene announced the publication of “Protein Corona Composition of Gold Nanocatalysts” in the ACS Pharmacology & Translational Science journal Clene (NASDAQ: CLNN), a late-stage clinical biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), along with its wholly-owned subsidiary…

TuesdayMay 14, 2024 9:00 am

HealthLynked Corp. (HLYK) Setting New Standard for Efficient Healthcare, Including Virtual Healthcare

HealthLynked leverages innovative cutting-edge technology and connectivity to make healthcare more efficient for patients and doctors The company’s HealthLynked Network, a comprehensive and sophisticated cloud-based healthcare platform, connects patients, healthcare providers, and medical facilities, providing centralized information access and communication Through its sophisticated platform, HealthLynked is changing how patients and medical professionals can, for example, interact with telehealth and telemedicine services The network facilitates real-time interactions between healthcare providers and patients, greatly improving the efficient delivery of healthcare information and services remotely through a user-facing app, securely transmitting needed patient data on demand HealthLynked (OTCQB: HLYK) offers cutting-edge technology and…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Category: Uncategorized

Annovis Bio Inc. (NYSE: ANVS) Is ‘One to Watch’

Astrotech Corp. (NASDAQ: ASTC) Subsidiary, “1st Detect”, Focuses on Superior Narcotics Trace Detection For Airport and Other Security Sites

Clene Inc. (NASDAQ: CLNN) Announces Updates on ACT-EAP for CNM-Au8(R) Compassionate Use

HealthLynked Corp. (HLYK) Continues to Expand AI Capabilities

PaxMedica Inc. (NASDAQ: PXMD) Shares Corporate Update and Commitment to Advancing Therapies for Neurological Disorders, Prepares for Key Engagements with the FDA

Clene Inc. (NASDAQ: CLNN) Participates in Three Investor Conferences During May 2024, Promoting CNM-Au8(R) Neuronal Health Therapy

PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis

HealthLynked Corp. (HLYK) Can Add Tens-of-thousands of Members by Improving Care for Students vis-à-vis its Affinity Marketing Efforts to U.S. Universities

Clene Inc. (NASDAQ: CLNN) Announces Key Operational Highlights as part of First Quarter 2024 Financial Results

HealthLynked Corp. (HLYK) Setting New Standard for Efficient Healthcare, Including Virtual Healthcare

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search